Class information for:
Level 1: ORAL PROTEINS//IFR Y1221//UPR 9045 CNRS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
24547 258 32.4 59%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
892 10711 JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ORAL PROTEINS Author keyword 4 67% 2% 4
2 IFR Y1221 Address 2 67% 1% 2
3 UPR 9045 CNRS Address 2 67% 1% 2
4 BIOMED SCI IMMUNOL Address 1 50% 1% 2
5 NEUROLMULTIPLE SCLEROSIS GRP Address 1 100% 1% 2
6 ORAL INTERFERON ALPHA Author keyword 1 100% 1% 2
7 ADOPTIVE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS Author keyword 1 50% 0% 1
8 ANIM WELF IMMUNOPROPHYLAXIS Address 1 50% 0% 1
9 BRONCHOALVEOLAR LEUKOCYTES Author keyword 1 50% 0% 1
10 CANINE INTERFERON ALPHA Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 ORAL PROTEINS 4 67% 2% 4 Search ORAL+PROTEINS Search ORAL+PROTEINS
2 ORAL INTERFERON ALPHA 1 100% 1% 2 Search ORAL+INTERFERON+ALPHA Search ORAL+INTERFERON+ALPHA
3 ADOPTIVE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS 1 50% 0% 1 Search ADOPTIVE+EXPERIMENTAL+AUTOIMMUNE+ENCEPHALOMYELITIS Search ADOPTIVE+EXPERIMENTAL+AUTOIMMUNE+ENCEPHALOMYELITIS
4 BRONCHOALVEOLAR LEUKOCYTES 1 50% 0% 1 Search BRONCHOALVEOLAR+LEUKOCYTES Search BRONCHOALVEOLAR+LEUKOCYTES
5 CANINE INTERFERON ALPHA 1 50% 0% 1 Search CANINE+INTERFERON+ALPHA Search CANINE+INTERFERON+ALPHA
6 CYTOKINE SYSTEM 1 50% 0% 1 Search CYTOKINE+SYSTEM Search CYTOKINE+SYSTEM
7 HEPATITIS B VIRUS MARKER 1 50% 0% 1 Search HEPATITIS+B+VIRUS+MARKER Search HEPATITIS+B+VIRUS+MARKER
8 IMMUNOACTIVE PROTEIN 1 50% 0% 1 Search IMMUNOACTIVE+PROTEIN Search IMMUNOACTIVE+PROTEIN
9 INNATE ANTIVIRAL 1 50% 0% 1 Search INNATE+ANTIVIRAL Search INNATE+ANTIVIRAL
10 NATURAL KILLER CELL CYTOLYTIC ACTIVITY 1 50% 0% 1 Search NATURAL+KILLER+CELL+CYTOLYTIC+ACTIVITY Search NATURAL+KILLER+CELL+CYTOLYTIC+ACTIVITY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 INGESTED IFN ALPHA 2 67% 1% 2
2 EXERT 2 43% 1% 3
3 BONE MARROW FUNCTION 1 100% 1% 2
4 ORAL USE 1 22% 2% 5
5 HUMAN INTERFERON ALPHA 1 13% 3% 8
6 INVIVO MYELOSUPPRESSION 1 50% 0% 1
7 ORAL INTERLEUKIN 6 1 29% 1% 2
8 INTERFERON ALPHA GENES 0 17% 1% 2
9 SENSITIVE RADIOIMMUNOASSAY 0 10% 1% 3
10 IPEC J2 0 25% 0% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Systemic effects of interferons after oral administration in animals and humans 2005 34 115 52%
Oral use of interferon 1999 19 41 78%
Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases 2008 6 85 40%
Immunomodulation and therapeutic effects of the oral use of interferon-alpha: Mechanism of action 1999 75 47 19%
The oropharyngeal delivery of interferons: Where are we and where do we need to go? 1999 10 19 63%
Systemic effects of orally administered interferons and interleukin-2 1999 7 23 57%
Gut response - Therapy with ingested immunomodulatory proteins 1997 2 6 67%
ORAL USE OF HUMAN ALPHA-INTERFERON IN CATS 1988 78 34 24%
Ingested type I interferon: A potential treatment for autoimmunity 2002 13 123 26%
Clinical application of interferons in large animal medicine 1996 17 33 36%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 IFR Y1221 2 67% 0.8% 2
2 UPR 9045 CNRS 2 67% 0.8% 2
3 BIOMED SCI IMMUNOL 1 50% 0.8% 2
4 NEUROLMULTIPLE SCLEROSIS GRP 1 100% 0.8% 2
5 ANIM WELF IMMUNOPROPHYLAXIS 1 50% 0.4% 1
6 GALWAY TECHNOL 1 50% 0.4% 1
7 INFANT SPECIAL CARE UNIT 1 50% 0.4% 1
8 MULTIPLE SCLEROSIS GRP 1 11% 2.3% 6
9 CIC VACCINOL COCHIN PASTEUR CIC BT505 0 33% 0.4% 1
10 QUANTITAT GENOM CORE 0 33% 0.4% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000204609 JOURNAL OF INTERFERON RESEARCH//TEXAS REPORTS ON BIOLOGY AND MEDICINE//JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS
2 0.0000116247 ADENOVIRAL MEDIATED INTERFERON ALPHA//GENE IMMUNE MED//CANC BIOL 173
3 0.0000107323 ISOFATTY ACID//COOPERAT MED//MNSF BETA
4 0.0000082207 BACTERIAL INVASIVENESS//BLOOD DERIVED MONOCYTES//BNITM
5 0.0000079915 BIOL GENET BACTERIAL CELL WALL//FC GAMMA RIII ALPHA//HUMAN INJECTIONS
6 0.0000077316 FELINE HERPESVIRUS TYPE 1//FELINE CALICIVIRUS//CHLAMYDOPHILA FELIS
7 0.0000076131 IMMUNE ENDOCRINE//HISTOTYPIC CULTURES//MERVIN BOVAIRD STUDIES MOL BIOL BIOTECHNOL
8 0.0000068858 PLASMACYTOID DENDRITIC CELLS//BDCA 4//PLASMACYTOID DENDRITIC CELL
9 0.0000068671 PARAMUNITY INDUCER//LEHRSTUHL MIKROBIOL SEUCHENLEHRE//PARAPOXVIRUS OVIS
10 0.0000067028 BOVINE HERPESVIRUS 1//BOHV 5//INFECTIOUS BOVINE RHINOTRACHEITIS